125 filings
Page 4 of 7
6-K
akn d2ylpkohmp
2 Jan 20
Current report (foreign)
5:09pm
6-K
r9f 0q19mbzw1s0
2 Jan 20
Current report (foreign)
11:43am
6-K
4kdkwswi5yqnzqe
20 Dec 19
Current report (foreign)
11:25am
6-K
uf8eq6 r7m
19 Dec 19
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
11:42am
6-K
a84ly
17 Dec 19
Current report (foreign)
1:26pm
6-K
ryn2w ah2zwmr
13 Dec 19
Current report (foreign)
7:54am
6-K
xcqfaba504ipa7
6 Dec 19
Current report (foreign)
12:00am
6-K
u3mgjrkga6 0v236qci
6 Dec 19
Current report (foreign)
12:00am
6-K
hc1fu
5 Dec 19
Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
9:28am
6-K
7hw95wpjsh5
19 Nov 19
Current report (foreign)
1:07pm
6-K
dzuv2q
13 Nov 19
Current report (foreign)
1:37pm
6-K
0tgix648m
12 Nov 19
Current report (foreign)
4:42pm
6-K
p9mvh4k6b
12 Nov 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:08pm
6-K
tx2t8i5apc87914 wyqv
6 Nov 19
Interim Report for the First Nine Months Ended September 30, 2019
3:37pm
6-K
nlt wrsliticpf
30 Oct 19
Current report (foreign)
5:11pm
6-K
mi7xf6rj
22 Oct 19
Current report (foreign)
9:45am
6-K
6cqabf 6xsrtm6
18 Oct 19
CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
9:25am
6-K
jmuue12
17 Oct 19
Current report (foreign)
1:19pm
6-K
4exg4y3bg0sc49t5h8h
15 Oct 19
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2019
8:21am
6-K
s0ocqr8dimgtslod9 ie
2 Oct 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:50pm